Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(HCDI)MC $26 M-Float 2 M -New Nasdaq Company with great upside potential
Harbor Custom Development, Inc. Announces Third Quarter Financial Results Highlighted by 15% Increase in Sales
https://finance.yahoo.com/news/harbor-custom-development-inc-announces-100000200.html
(RHE)MC $3 M--O/S 1.7 M-MEGA BREAKOUT IMMINENT---Price $1.62
(RHE)MC $3 M--O/S 1.7 M-MEGA BREAKOUT IMMINENT---Price $1.62
(RHE)MC $3 M--O/S 1.7 M-MEGA BREAKOUT IMMINENT---Price $1.62
(SNDE) Price $2.36-Book value $55 PER Share / Shares Out 6.8 Million / Oil Company = Potential 10 Bagger
SNDE =Price 2.38- Book Value $55 PER SHARE / Market Cap $28 million ...this underpriced low float genm is about to jump ,,only 6.8 million outstanding shares
(MARPS)MC $3 M-RALLYYYYYYYYYYYYYYYYYYY
(MARPS) MC $3 M-Shares Out 2 M-Profitable Oil Company / price $1.75...Undiscovered low float monster which could hit $10 in NO time ....LIFETIME OPP guys
MARPS =MC $3 M -RALLYYYYYYYYYYYYYYYYYYYYY
(MARPS) MC $3 M-Shares Out 2 M-Profitable Oil Company / price $1.75...Undiscovered low float monster which could hit $10 in NO time ....LIFETIME OPP guys
MARPS =MC $3 M RALLLYYYYYYYYYYYYYYYYYY
(MARPS) MC $3 M-Shares Out 2 M-Profitable Oil Company / price $1.75...Undiscovered low float monster which could hit $10 in NO time ....LIFETIME OPP guys
ETON =2x FDA DECISIONS in September ,,HUGE buying opp on the dip today
GeoVax (GOVX) MCap $7 MILLION / Covid 19 Vaccine to Start Phase 1/2 very soon and government funding also are IMMINENT = Potential next 10 Bagger or even more ..GLTA
https://www.geovax.com/images/200401_GOVX_Fact_Sheet.pdf
CTIC =CHEAPEST Cocid Phase 3 Gem
(CTIC) MCap $105 M / Cash $81 M/ 2x PHASE 3 Drugs with first results in Q4 for the Covid 19 Drug / UNDISCOVERED gem = Next potential 10 BAGGER
https://assets.wallstreet-online.de/_media/8763/board/20200715162807-screenshot-2020-07-15-powerpoint-presentation-832.png
GOVX =MC $6 M -Covid 19 Vaccine gem ,,this low float stock is very interesting at this time because they could receive government funding anytime now this would be SIGNIFICANT News for the company and could push the sp to $2 or much higher .. click link below to watch the interview
GeoVax (GOVX)
Market Cap $6.5 Million
Price 0.45
Shares Out 13.8 Million
Pharmaceutical industry is in an 'unprecedented race' for a COVID-19 vaccine: GeoVax CEO
https://finance.yahoo.com/video/pharmaceutical-industry-unprecedented-race-covid-154231700.html
GOVX =MC $6 M -Covid 19 Vaccine gem ,,this low float stock is very interesting at this time because they could receive government funding anytime now this would be SIGNIFICANT News for the company and could push the sp to $2 or much higher .. click link below to watch the interview
Pharmaceutical industry is in an 'unprecedented race' for a COVID-19 vaccine: GeoVax CEO
https://finance.yahoo.com/video/pharmaceutical-industry-unprecedented-race-covid-154231700.html
CTIC =Covid Phase 3 Data in Q4
Covid 19 Drug with Phase 3 Data in Q4 a potential 10+ BAGGER
CTIC = MCap $97 M /Cash $81 M/ Covid 19 Drug with Phase 3 results in Q4 /UNDISCOVERED gem
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
https://finance.yahoo.com/news/cti-biopharma-announces-enrollment-first-110000668.html
- Company Expects to Report Topline Data by the End of 2020 -
Covid 19 Drug with Phase 3 Data in Q4 a potential 10+ BAGGER
CTIC = MCap $97 M /Cash $81 M/ Covid 19 Drug with Phase 3 results in Q4 /UNDISCOVERED gem =20 BAGGER ...LIFETIME OPP
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
https://finance.yahoo.com/news/cti-biopharma-announces-enrollment-first-110000668.html
- Company Expects to Report Topline Data by the End of 2020 -
CTIC =MC $97 M/Phase 3 data of Covid 19 Drug in Q4 ...MEGA Potential here maybe next 10 Bagger or moe ..Price $1.32
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
https://finance.yahoo.com/news/cti-biopharma-announces-enrollment-first-110000668.html
- Company Expects to Report Topline Data by the End of 2020 -
CTIC =MC $97 M/Phase 3 data of Covid 19 Drug in Q4 ...MEGA Potential here maybe next 10 Bagger or moe ..Price $1.32
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
https://finance.yahoo.com/news/cti-biopharma-announces-enrollment-first-110000668.html
- Company Expects to Report Topline Data by the End of 2020 -
SNGX = MCap $52 Mil / 3x ORPHAN Drugs in Phase 3 with data in Q4 / Covid 19 Vaccine / low float =CHEAPEST of ALL Covid 19 Vaccine GEMS potential 10 bagger
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
SNGX = MCap $52 Mil / 3x ORPHAN Drugs in Phase 3 with data in Q4 / Covid 19 Vaccine / low float =CHEAPEST of ALL Covid 19 Vaccine GEMS could run like ALT or VXRT very soon
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
GENX.V (MC $10M)Covid 19 treatment to be marketed very soon
COMPLETELY undiscovered and very cheap stock with brutally upside...This stock which trading at 18 cents could run to $5 and much higher because of current Corona hype .. as an example Sona Nanotech (SONA.C) another canadian Corona gem explodes from 12 cents to $9 .This could be a MONSTER Pick for the coming days and weeks .GLTA
Genix Pharma (GENX.V) canadian stock
Market Cap: C$10.5 Million (= around US$ 7.5 Million)
Price 0.20
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html
A Novel and Proprietary Anti-Viral, Anti-Flu and Common Colds Coronavirus Spray
"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz
GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
GENX.V (MC $10M)Covid 19 treatment to be marketed very soon
COMPLETELY undiscovered and very cheap stock with brutally upside...This stock which trading at 18 cents could run to $5 and much higher because of current Corona hype .. as an example Sona Nanotech (SONA.C) another canadian Corona gem explodes from 12 cents to $9 .This could be a MONSTER Pick for the coming days and weeks .GLTA
Genix Pharma (GENX.V) canadian stock
Market Cap: C$10.5 Million (= around US$ 7.5 Million)
Price 0.20
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html
A Novel and Proprietary Anti-Viral, Anti-Flu and Common Colds Coronavirus Spray
"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz
GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
GENX.V =MC $7 M /Selling COVID 19 TREATMENT =LIFETIME OPP ??
COMPLETELY undiscovered and very cheap stock with brutally upside...This stock which trading at 18 cents could run to $5 and much higher because of current Corona hype .. as an example Sona Nanotech (SONA.C) another canadian Corona gem explodes from 12 cents to $9 .This could be a MONSTER Pick for the coming days and weeks .GLTA
Genix Pharma (GENX.V)
Market Cap: C$9.7Million (= around US$ 7.1 Million)
Price 0.185
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html
A Novel and Proprietary Anti-Viral, Anti-Flu and Common Colds Coronavirus(1) Spray
"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz
GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
GENX.V =MC $7 M /Selling COVID 19 TREATMENT =LIFETIME OPP ??
COMPLETELY undiscovered and very cheap stock with brutally upside...This stock which trading at 18 cents could run to $5 and much higher because of current Corona hype .. as an example Sona Nanotech (SONA.C) another canadian Corona gem explodes from 12 cents to $9 .This could be a MONSTER Pick for the coming days and weeks .GLTA
Genix Pharma (GENX.V)
Market Cap: C$9.7Million (= around US$ 7.1 Million)
Price 0.185
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html
A Novel and Proprietary Anti-Viral, Anti-Flu and Common Colds Coronavirus(1) Spray
"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz
GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
GENX.V =MC $7 M /Selling COVID 19 TREATMENT =LIFETIME OPP ??
COMPLETELY undiscovered and very cheap stock with brutally upside...This stock which trading at 18 cents could run to $5 and much higher because of current Corona hype .. as an example Sona Nanotech (SONA.C) another canadian Corona gem explodes from 12 cents to $9 .This could be a MONSTER Pick for the coming days and weeks .GLTA
Genix Pharma (GENX.V)
Market Cap: C$9.7Million (= around US$ 7.1 Million)
Price 0.185
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html
A Novel and Proprietary Anti-Viral, Anti-Flu and Common Colds Coronavirus(1) Spray
"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz
GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
ADOM =MCap $22 Mil /HOT EV gem / Price 0.28 / CHEAPEST EV gem / UNKNOWN stock = Next hot EV gem after AYRO Potential 5-10 bagger here
Potential in Adomani Electric
ADOM =MC 22 M --EV gem about to EXPLODEEEE
ADOM =MCap $22 Mil /HOT EV gem / Price 0.28 / CHEAPEST EV gem / UNKNOWN stock = Next hot EV gem after AYRO Potential 5-10 bagger here
Potential in Adomani Electric
ADOM =MC $19 M / a EV BOMB ..this has BRUTAL upside
Could hit $6 today and with positive phase 3 readout (expected during 2H 2020) this could explode toward 30 bucks
Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia
https://clinicaltrials.gov/ct2/show/record/NCT04351152?term=NCT04351152&draw=2&rank=1&view=record
HGEN =Phase 3 data for Covid 19 Drug very soon ,first results shows its more effective than Gileads drug ..Could be approved before year end if phase 3 is successful this would push the stock likely toward 30 dollar (current price $5)
"Humanigen's Lenzilumab Shows Promising Results In COVID-19 Trial
An analysis of the first clinical use of Humanigen Inc.'s (HGEN) investigational drug Lenzilumab in twelve COVID-19 patients has shown some encouraging results.
Lenzilumab is designed to prevent and/or treat cytokine storm that precedes severe lung dysfunction and ARDS (acute respiratory distress syndrome) in serious cases of SARS-CoV-2 infection.
Patients treated with Lenzilumab showed rapid clinical improvement with a median time to improvement of five days and a median time to recovery of five days. In comparison, patients treated with Gilead's Remdesivir demonstrated a median time to the improvement of 10 to 11 days and a median time to recovery of 10 to 11 days.
Remdesivir was granted emergency use authorization based on time to recovery of 11 days in the Adaptive COVID-19 Treatment Trial (ACTT-1).
A potential registrational phase III study of Lenzilumab in COVID-19 patients is currently enrolling. "
HGEN or CYDY ...looks like HGENs lenzilumab is very effective as a covid 19 treatment which is in FINAL phase 3 trial with data coming in short term . HGEN is much cheaper than CYDY ..
Therapeutics with the best data reported in the past month are remdesivir, lenzilumab and dexamethasone.
Humanigen Inc., however, reported in June that its Humaneered anti-human-GM-CSF monoclonal antibody lenzilumab led to a median time to improvement and recovery in 12 patients of five days vs. the 10 to 11 days with remdesivir. Although it is a small victory as part of a compassionate use program, all eyes will be on the company’s phase III trial currently enrolling 238 hospitalized COVID-19 pneumonia patients.
https://www.bioworld.com/articles/436226-snowballing-research-preps-avalanche-to-bury-covid-19
$20+ stock on positive phase 3 readout of the covid 19 trial
Coronavirus (COVID-19) Therapeutic Treatment: The Potential of Lenzilumab | Cytokine Storms
SNGX = MCap $55 Mil /Covid 19 Vaccine / 3x Phase 3 Drugs with data in Q4 / low float =Next Potential move here like NVAX or INO
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html
SNGX = MCap $55 Mil / 3x Phase 3 Drugs with data in Q4 / Covid 19 Vaccine / low float =LNext Potential NVAX or INO here
http://news.santafenewsonline.com/story/205021/soligenix-inc-set-to-leverage-its-milestone-filled-2019-toward-a-transformational-2020-chief-scientific-officer-featured-in-pharmavoice-podcast.html